YOLFTbeta
Medical Developments International Ltd

Medical Developments International Ltd

MVP · AU · Healthcare / Drug Manufacturers - Specialty & Generic

0.43AUD-0.01 (-2.27%)

Price History

Full chart

Market Stats

Previous Close0.44
Open0.43
Day Range0.43 – 0.445
52-Week Range0.365 – 0.765
Volume386.88K
Market Cap47.88M
P/E (TTM)42.50
Forward P/E166.67
EPS0.01
Dividend Yield0.00%
Beta1.41
50-Day Avg0.4711
200-Day Avg0.4466

About

Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The company also supplies respiratory products, including space chambers, peak flow meters, portable nebulizers, and silicone face masks to aid sufferers of asthma and chronic obstructive pulmonary disease. Medical Developments International Limited was founded in 1972 and is headquartered in Scoresby, Australia.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Brent MacGregor
  • Employees0
  • Headquarters4 Caribbean Drive, Scoresby, VIC, Australia, 3179, Australia
  • Websitehttps://medicaldev.com

Leadership

  • Mr. Brent MacGregorChief Executive Officer · b. 1964
  • Ms. Anita JamesChief Financial Officer
  • Ms. Anastasia TanHead of Operations & Supply Chain
  • Ms. Tara Eaton L.L.B., L.L.M.Chief Corporate & People Officer
  • Wayne PearceHead of Production
  • Ms. Julianne AlexanderHead of Medical Affairs, Regulatory Affairs & Clinical Development
  • Mr. Benson LeeHead of Commercial Operations
  • Ms. Victoria SowemimoHead of Quality

Financials

Income Statement

Currency: AUD2003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue5.47M3.05M5.40M6.61M7.40M9.22M8.73M8.30M10.21M11.31M11.73M9.37M11.61M15.47M18.35M17.46M20.88M22.54M25.27M21.94M32.34M33.15M39.06M42.57M
Growth (%)--44.33%+77.30%+22.22%+11.98%+24.65%-5.34%-4.94%+23.02%+10.85%+3.71%-20.14%+23.88%+33.28%+18.59%-4.83%+19.56%+7.95%+12.15%-13.17%+47.37%+2.51%+17.82%+8.99%
Cost of Revenue-1.04M1.93M2.23M2.51M3.50M3.03M2.99M3.67M3.47M3.40M3.05M3.55M4.26M5.76M5.10M6.69M8.80M8.60M25.00M34.85M8.78M9.63M30.59M
Gross Profit5.47M2.01M3.48M4.37M4.89M5.72M5.70M5.30M6.54M7.85M8.33M6.32M8.05M11.21M12.58M12.36M14.18M13.74M16.67M-3.06M-2.52M24.37M29.43M11.98M
Gross Margin100.00%65.88%64.36%66.16%66.10%62.09%65.27%63.93%64.05%69.35%71.00%67.45%69.38%72.46%68.58%70.81%67.94%60.96%65.98%-13.95%-7.78%73.50%75.35%28.15%
Operating Expense347.00K1.57M3.58M3.31M3.37M4.81M4.98M4.44M4.65M4.66M4.55M4.61M5.12M7.66M9.08M10.29M11.01M11.87M21.91M12.63M17.93M41.23M26.35M10.92M
Operating Income5.13M438.00K-107.00K1.06M1.51M912.00K717.00K863.00K1.88M3.19M3.78M1.71M2.93M3.56M3.50M2.07M3.17M1.87M-5.24M-15.70M-20.44M-16.87M3.07M1.06M
Operating Margin93.66%14.37%-1.98%16.03%20.48%9.89%8.22%10.40%18.45%28.19%32.20%18.25%25.26%22.98%19.08%11.85%15.20%8.31%-20.73%-71.53%-63.22%-50.88%7.87%2.48%
EBITDA5.47M1.14M1.13M1.57M2.05M1.63M1.55M1.63M2.25M3.44M4.01M959.00K2.63M3.42M3.80M2.22M3.89M3.03M-11.11M-12.86M-4.28M-29.45M1.67M3.74M
EBITDA Margin100.00%37.34%20.91%23.80%27.73%17.63%17.72%19.60%22.05%30.37%34.17%10.23%22.69%22.11%20.73%12.73%18.62%13.45%-43.96%-58.61%-13.25%-88.83%4.29%8.79%
Net Income-481.00K168.00K797.00K1.21M891.00K810.00K879.00K1.74M2.70M2.31M875.00K1.53M1.57M1.82M243.00K1.04M379.00K-12.56M-12.41M-5.61M-40.99M94.00K626.00K
Net Income Margin-15.78%3.11%12.07%16.32%9.66%9.28%10.60%17.08%23.90%19.68%9.34%13.17%10.14%9.92%1.39%4.97%1.68%-49.72%-56.54%-17.35%-123.66%0.24%1.47%
R&D---28.00K74.00K31.00K1.00K16.00K15.00K75.00K41.00K99.00K200.00K164.00K199.00K359.00K510.00K396.00K536.00K220.00K236.00K313.00K271.00K-
R&D as % of Total Revenue---0.42%1.00%0.34%0.01%0.19%0.15%0.66%0.35%1.06%1.72%1.06%1.08%2.06%2.44%1.76%2.12%1.00%0.73%0.94%0.69%-
Interest Expense0124.00K176.00K169.00K100.00K6.00K13.00K1.00K000156.00K81.00K24.00K7.00K140.00K71.00K114.00K121.00K103.00K95.00K86.00K75.00K65.00K
Interest Expense % of Total Revenue0.00%4.07%3.26%2.56%1.35%0.07%0.15%0.01%0.00%0.00%0.00%1.66%0.70%0.16%0.04%0.80%0.34%0.51%0.48%0.47%0.29%0.26%0.19%0.15%

Balance Sheet

Currency: AUD2003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets11.63M12.47M11.55M12.50M12.12M13.19M13.39M14.21M16.71M19.14M20.28M22.56M22.99M41.24M41.76M49.55M84.80M94.85M100.17M101.36M109.49M59.16M66.40M68.58M
Total Liabilities4.13M4.10M3.15M2.63M1.09M1.39M1.58M1.50M2.26M2.97M4.55M6.74M5.58M22.21M20.16M28.51M40.21M51.51M31.87M44.06M28.17M13.43M11.29M12.77M
Total Equity7.50M8.37M8.40M9.87M11.02M11.80M11.81M12.71M14.46M16.17M15.73M15.82M17.41M19.02M21.60M21.04M44.59M43.34M68.30M57.30M81.31M45.73M55.10M55.81M
Cash980.00K1.70M542.00K1.02M335.00K473.00K257.00K1.78M3.54M3.48M768.00K1.66M954.00K5.62M1.69M794.00K25.62M15.54M36.28M20.40M24.66M9.73M17.84M14.37M
Total Debt4.00M2.50M2.00M2.04M250.00K-----1.44M3.66M1.11M481.00K429.00K9.25M182.00K3.36M3.05M2.81M2.56M2.29M1.99M1.67M
Net Debt3.02M799.00K1.46M1.02M-85.00K-473.00K-257.00K-1.78M-3.54M-3.48M676.00K2.00M157.00K-5.14M-1.26M8.46M-25.44M-12.19M-33.23M-17.59M-22.10M-7.45M-15.85M-12.70M

Cash Flow

Currency: AUD2004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow401.00K569.00K1.15M1.27M1.23M1.28M1.81M3.03M3.20M977.00K1.29M3.36M12.07M4.01M1.79M21.27M172.00K-8.81M-10.72M-16.50M-10.78M-43.00K5.75M
Investing Cash Flow-9.09M-579.00K-175.00K-128.00K-642.00K-617.00K-283.00K-1.30M-2.17M-2.95M-1.84M-1.51M-6.15M-8.67M-10.68M-9.54M-8.47M-6.56M-5.21M-7.67M-3.17M-1.04M-7.79M
Financing Cash Flow10.39M-1.14M-500.00K-1.79M-424.00K-830.00K---1.09M-737.00K1.46M-2.58M-1.26M695.00K7.97M13.04M-1.97M36.12M142.00K28.06M-807.00K8.68M-798.00K
Capital Expenditure80.00K342.00K261.00K137.00K843.00K609.00K283.00K1.30M2.17M542.00K322.00K555.00K1.42M4.35M2.06M1.49M8.90M6.56M5.21M7.67M3.17M443.00K481.00K
Free Cash Flow321.00K227.00K891.00K1.13M385.00K675.00K1.53M1.73M1.02M435.00K973.00K2.80M10.65M-342.00K-268.00K19.78M-8.73M-15.37M-15.94M-24.16M-13.95M-486.00K5.27M
Dividends Paid-142.00K------1.22M2.31M760.00K623.00K623.00K1.24M1.24M1.72M2.06M35.53M139.00K26.38M---
FCF to OCF80.05%39.89%77.34%89.19%31.35%52.57%84.37%57.01%32.02%44.52%75.14%83.48%88.22%-8.53%-14.97%93.01%-5075.00%174.48%148.63%146.47%129.40%1130.23%91.63%
Dividend Paid to FCF-62.56%------119.24%530.80%78.11%22.22%5.85%-361.99%-462.31%8.68%-23.66%-231.19%-0.87%-109.18%---

Earnings

Report DateFeb 22, 2016Aug 18, 2016Feb 20, 2017Aug 18, 2017Feb 16, 2018Aug 16, 2018Feb 19, 2019Aug 20, 2019Feb 19, 2020Aug 20, 2020Feb 25, 2021Aug 25, 2021Feb 24, 2022Aug 26, 2022Feb 24, 2023Feb 19, 2025May 28, 2025Aug 20, 2025Dec 3, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.00----0.000.000.000.00
EPS Actual0.000.020.010.020.000.000.000.010.000.00-0.02-0.16-0.10-0.070.030.000.000.000.00
Surprise----------100.00%---------
Timing-----------After-hours-Pre-marketAfter-hours----

Key Statistics & Ratios

Market Cap47.88M
Enterprise Value31.00M
Trailing P/E42.50
Forward P/E166.67
PEG Ratio0.00
Price / Sales1.12
Price / Book0.91
EPS0.01
Book Value0.495
Revenue (TTM)42.57M
Gross Profit (TTM)30.67M
EBITDA3.96M
Profit Margin1.47%
Operating Margin8.11%
Return on Equity1.13%
Return on Assets2.28%
Shares Outstanding112.66M
Shares Float76.53M
Beta1.41
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
24.01%
Insiders
23.92%
Retail / Other
52.07%

Top Fund Holders

  • SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF
    32.21K0.05%

Dividends

20201×
0.02Mar 5, 2020
20192×
0.02Sep 3, 20190.02Mar 7, 2019
20182×
0.02Aug 30, 20180.02Mar 2, 2018
20172×
0.02Aug 31, 20170.02Mar 3, 2017
20162×
0.02Sep 1, 20160.02Mar 2, 2016
20132×
0.02Sep 2, 20130.03Feb 27, 2013
20122×
0.03Aug 30, 20120.03Feb 28, 2012
20111×
0.03Aug 31, 2011
20041×
0.00Oct 13, 2004